Literature DB >> 28147224

Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.

Jae Kwan Jun1, Kui Son Choi2, Hoo-Yeon Lee3, Mina Suh4, Boyoung Park1, Seung Hoon Song4, Kyu Won Jung4, Chan Wha Lee5, Il Ju Choi6, Eun-Cheol Park7, Dukhyoung Lee1.   

Abstract

BACKGROUND & AIMS: It is not clear whether screening for gastric cancer by upper endoscopy or upper gastrointestinal (UGI) series examinations (looking at the upper and middle sections of the gastrointestinal tract by imaging techniques) reduces mortality. Nevertheless, the Korean National Cancer Screening Program for gastric cancer was launched in 1999 to screen individuals 40 years and older for gastric cancer using these techniques. We evaluated the effectiveness of these techniques in gastric cancer detection and compared their effects on mortality in the Korean population.
METHODS: We performed a nested case-control study using data from the Korean National Cancer Screening Program for gastric cancer since 2002. A total of 16,584,283 Korean men and women, aged 40 years and older, comprised the cancer-free cohort. Case subjects (n = 54,418) were defined as individuals newly diagnosed with gastric cancer from January 2004 through December 2009 and who died before December 2012. Cases were matched with controls (subjects who were alive on the date of death of the corresponding case subject, n = 217,672) for year of entry into the study cohort, age, sex, and socioeconomic status. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained via conditional logistic regression analysis.
RESULTS: Compared with subjects who had never been screened, the overall OR for dying from gastric cancer among ever-screened subjects was 0.79 (95% CI, 0.77-0.81). According to screening modality, the ORs of death from gastric cancer were 0.53 (95% CI, 0.51-0.56) for upper endoscopy and 0.98 (95% CI, 0.95-1.01) for UGI series. As the number of endoscopic screening tests performed per subject increased, the ORs of death from gastric cancer decreased: 0.60 (95% CI, 0.57-0.63), 0.32 (95% CI, 0.28-0.37), and 0.19 (95% CI, 0.14-0.26) for once, twice, and 3 or more times, respectively.
CONCLUSIONS: Within the Korean National Cancer Screening Program, patients who received an upper endoscopy were less likely to die from gastric cancer; no associations were found for UGI series.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopy; Mass Screening; Photofluorography; Stomach Neoplasms

Mesh:

Year:  2017        PMID: 28147224     DOI: 10.1053/j.gastro.2017.01.029

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  112 in total

1.  Clinical outcomes of endoscopic submucosal dissection for lesions on the proximal location between remnant and entire stomach.

Authors:  Su Jin Kim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.

Authors:  Mitsushige Sugimoto; Masaki Murata; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

3.  Screening endoscopy for gastric cancer: time for quality control.

Authors:  Eun Hye Kim; Chan Hyuk Park
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-27

4.  Quality standards and performance measures: steps to high quality diagnostic endoscopy.

Authors:  Yu Kyung Cho
Journal:  Transl Gastroenterol Hepatol       Date:  2018-01-28

Review 5.  Helicobacter pylori Infection: New Facts in Clinical Management.

Authors:  Peter Malfertheiner; Marino Venerito; Christian Schulz
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

6.  How long should patients be surveyed for gastric cancer risk after Helicobacter pylori eradication therapy? 10 years is no longer enough.

Authors:  Mitsushige Sugimoto; Masaki Murata; Takashi Kawai
Journal:  J Gastroenterol       Date:  2020-02-05       Impact factor: 7.527

7.  Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans.

Authors:  Christie Y Jeon; Yu-Chen Lin; Samuel J Klempner; Bechien U Wu; Sungjin Kim; Kevin M Waters; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-19

8.  Utilizing Cultural and Ethnic Variables in Screening Models to Identify Individuals at High Risk for Gastric Cancer: A Pilot Study.

Authors:  Haejin In; Ian Solsky; Philip E Castle; Clyde B Schechter; Michael Parides; Patricia Friedmann; Judith Wylie-Rosett; M Margaret Kemeny; Bruce D Rapkin
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-14

9.  Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.

Authors:  Won Hyeok Choe; Jeong Hwan Kim; Jung Ho Park; Heung Up Kim; Dae Hyeon Cho; Sang Pyo Lee; Tae Yoon Lee; Sun-Young Lee; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2017-12-27       Impact factor: 3.199

10.  Comparison of long-term oncologic outcomes laparoscopy-assisted gastrectomy and open gastrectomy for gastric cancer.

Authors:  Xin-Yu Mao; Hua Zhu; Wei Wei; Xin-Lei Xu; Wei-Zhi Wang; Bao-Lin Wang
Journal:  Langenbecks Arch Surg       Date:  2020-10-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.